Urine CXCL10/IP-10 Fingers Ongoing Antibody-Mediated Kidney Graft Rejection.
作者信息
Fairchild Robert L, Suthanthiran Manikkam
机构信息
Department of Immunology and the Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio; andJoan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medical Center, New York, New York.
Department of Immunology and the Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio; andJoan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medical Center, New York, New York
出版信息
J Am Soc Nephrol. 2015 Nov;26(11):2607-9. doi: 10.1681/ASN.2015040353. Epub 2015 May 6.
Abstract
摘要
相似文献
1
Urine CXCL10/IP-10 Fingers Ongoing Antibody-Mediated Kidney Graft Rejection.尿液CXCL10/IP-10提示持续性抗体介导的肾移植排斥反应。
J Am Soc Nephrol. 2015 Nov;26(11):2607-9. doi: 10.1681/ASN.2015040353. Epub 2015 May 6.
2
Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.尿C-X-C基序趋化因子10独立改善抗体介导的肾移植排斥反应的非侵入性诊断。
J Am Soc Nephrol. 2015 Nov;26(11):2840-51. doi: 10.1681/ASN.2014080797. Epub 2015 May 6.
3
The association of urinary interferon-gamma inducible protein-10 (IP10/CXCL10) levels with kidney allograft rejection.尿干扰素-γ诱导蛋白-10（IP10/CXCL10）水平与肾移植排斥反应的关系。
Inflamm Res. 2017 May;66(5):425-432. doi: 10.1007/s00011-017-1025-7. Epub 2017 Feb 28.
4
Association Between Graft Function and Urine CXCL10 and Acylcarnitines Levels in Kidney Transplant Recipients.移植肾功能与肾移植受者尿液 CXCL10 和酰基辅酶 A 水平的关系。
Lab Med. 2022 Jan 6;53(1):78-84. doi: 10.1093/labmed/lmab049.
5
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine.通过检测尿液中IP-10和CXCR3的mRNA对肾移植炎症进行无创检测。
Kidney Int. 2004 Jun;65(6):2390-7. doi: 10.1111/j.1523-1755.2004.00663.x.
6
Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.六个月尿CCL2和CXCL10水平可预测肾移植长期预后。
Transplantation. 2016 Sep;100(9):1988-96. doi: 10.1097/TP.0000000000001304.
7
Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function.肾移植后早期尿中IP-10表达可预测移植肾短期和长期功能。
Kidney Int. 2006 May;69(9):1683-90. doi: 10.1038/sj.ki.5000343.
8
Urinary CXCL-10, a prognostic biomarker for kidney graft injuries: a systematic review and meta-analysis.尿 CXCL-10，一种预测肾移植损伤的预后生物标志物：系统评价和荟萃分析。
BMC Nephrol. 2024 Sep 4;25(1):292. doi: 10.1186/s12882-024-03728-2.
9
Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.尿CXCL10与肌酐比值升高与小儿肾移植的亚临床和临床排斥反应相关。
Transplantation. 2015 Apr;99(4):797-804. doi: 10.1097/TP.0000000000000419.
10
Urine CXCL10 as a biomarker in kidney transplantation.尿液 CXCL10 作为肾移植的生物标志物。
Curr Opin Organ Transplant. 2024 Apr 1;29(2):138-143. doi: 10.1097/MOT.0000000000001135. Epub 2024 Jan 19.
引用本文的文献
1
Targeted Urine Metabolomics for Monitoring Renal Allograft Injury and Immunosuppression in Pediatric Patients.靶向尿液代谢组学用于监测小儿肾移植受者的移植肾损伤和免疫抑制状态
J Clin Med. 2020 Jul 22;9(8):2341. doi: 10.3390/jcm9082341.
2
Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study.BK 多瘤病毒复制的肾移植受者血液和尿液中 CXCL10 浓度的纵向评估——一项回顾性研究。
Transpl Int. 2020 May;33(5):555-566. doi: 10.1111/tri.13584. Epub 2020 Feb 13.
3
A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts.一种用于预测肾移植免疫损伤的计算基因表达评分
PLoS One. 2015 Sep 14;10(9):e0138133. doi: 10.1371/journal.pone.0138133. eCollection 2015.
本文引用的文献
1
Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.尿C-X-C基序趋化因子10独立改善抗体介导的肾移植排斥反应的非侵入性诊断。
J Am Soc Nephrol. 2015 Nov;26(11):2840-51. doi: 10.1681/ASN.2014080797. Epub 2015 May 6.
2
Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.尿液细胞 mRNA 谱与急性肾移植功能障碍的鉴别诊断。
J Am Soc Nephrol. 2014 Jul;25(7):1586-97. doi: 10.1681/ASN.2013080900. Epub 2014 Mar 7.
3
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.多中心验证尿 CXCL9 作为肾移植损伤的风险分层生物标志物。
Am J Transplant. 2013 Oct;13(10):2634-44. doi: 10.1111/ajt.12426. Epub 2013 Aug 22.
4
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.尿液细胞 mRNA 谱与肾移植的急性细胞排斥反应
N Engl J Med. 2013 Jul 4;369(1):20-31. doi: 10.1056/NEJMoa1215555.
5
Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.CXC 趋化因子受体 3（CXCR3）缺陷型 NOD 小鼠糖尿病的加速发展。
Diabetologia. 2012 Aug;55(8):2238-45. doi: 10.1007/s00125-012-2547-8. Epub 2012 Apr 11.
6
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches.肾移植中排斥反应的诊断：基于分子和组织病理学方法的比较
Am J Transplant. 2009 Aug;9(8):1802-10. doi: 10.1111/j.1600-6143.2009.02694.x. Epub 2009 Jun 10.
7
Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis.尿CXCL9和CXCL10水平与亚临床肾小管炎的程度相关。
Am J Transplant. 2009 Jun;9(6):1347-53. doi: 10.1111/j.1600-6143.2009.02645.x. Epub 2009 May 13.
8
Orchestrating the orchestrators: chemokines in control of T cell traffic.调控调控者：趋化因子对T细胞迁移的控制
Nat Immunol. 2008 Sep;9(9):970-80. doi: 10.1038/ni.f.213.
9
CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.CXCR3信号通路通过控制效应T细胞和调节性T细胞在中枢神经系统中的实质分布，降低实验性自身免疫性脑脊髓炎的严重程度。
J Immunol. 2007 Sep 1;179(5):2774-86. doi: 10.4049/jimmunol.179.5.2774.
10
T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity.T 细胞转录因子 T-bet 通过对迁移和效应活性的不同作用来控制心脏中细胞毒性 T 淋巴细胞的致病性。
J Immunol. 2006 Nov 1;177(9):5890-901. doi: 10.4049/jimmunol.177.9.5890.
Zotero 插件